Sign in / Join Now
ETFs & Funds
Dr. Reddy's Laboratories (
) looks poised to rise after its recent pullback.
Add a reply...
Latest StockTalks »
people get RDY breaking news and analysis by email alert.
Get email alerts on RDY »
Dr. Reddy's Laboratories Limited
Get latest price
From other sites
Dr. Reddy's Laboratories Limited To Present At The J.P. Morgan 35th Annual Healthcare Conference
at TheStreet (Jan 9, 2017)
The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen
at Zacks.com (Jan 4, 2017)
Dr. Reddy's Laboratories Announces The Launch Of Nystatin And Triamcinolone Acetonide Cream, USP In The U.S. Market
at TheStreet (Dec 5, 2016)
Dr. Reddy's Laboratories Announces The Launch Of Raloxifene HCl Tablets, USP In The U.S. Market
at TheStreet (Nov 11, 2016)
Dr. Reddy's Laboratories Announces New Strategic Deal With Gland Pharma In The U.S. Market
at TheStreet (Oct 26, 2016)